Kiniksa Pharmaceuticals International, Plc · NASDAQ:KNSA
Patel Sanj K exercised options for 21,327 Kiniksa Pharmaceuticals International, Plc shares (Form 4)
Traded Apr 1, 2026 · Filed Apr 3, 2026
On Apr 1, 2026, Patel Sanj K (Director, CHAIRMAN & CEO) exercised options for 21,327 Kiniksa Pharmaceuticals International, Plc shares, leaving 71,014 shares. Filed Apr 3, 2026 (Form 4).
- Options exercised
- 21,327 shares
- Holding after
- 71,014 shares (held indirectly)
- Trading plan
- No
- Role
- Director, CHAIRMAN & CEO
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Apr 1, 2026 | Class A Ordinary Share | Option exercise | 21,327 | 81,327 | Indirect | |
| Apr 1, 2026 | Class A Ordinary Share | Shares withheld for tax | 10,313 | US$48.13 | 71,014 | Indirect |
Source
Related
- Kiniksa Pharmaceuticals International, Plc
- Patel Sanj K
- Kiniksa Pharmaceuticals International, Plc shareholders
- Form 4 · Patel Sanj K · Sep 3, 2026
- Form 4 · Patel Sanj K · Jun 2, 2026
- Form 4 · Patel Sanj K · May 1, 2026
- Form 4 · Patel Sanj K · Apr 30, 2026
- Form 4 · Patel Sanj K · Apr 8, 2026
- Form 4 · Megna Michael R · Sep 3, 2026
- Form 4 · Paolini John F. · Sep 3, 2026
- Form 4 · Ragosa Mark · Sep 3, 2026
- Form 4 · Moat Ross · Sep 3, 2026
- Form 4 · Quart Barry D · Aug 21, 2026